Header Logo

Connection

HARSHAVARDHAN DODDAPANENI to Receptor, ErbB-2

Back to Details
This is a "connection" page, showing publications HARSHAVARDHAN DODDAPANENI has written about Receptor, ErbB-2.
HARSHAVARDHAN DODDAPANENI
Connection Strength
0.179
Receptor, ErbB-2
  1. Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers. Cell Rep Med. 2025 Jun 17; 6(6):102154.
    View in: PubMed
    Score: 0.179
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.